نتائج البحث - Adam Root

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    A myostatin and activin decoy receptor enhances bone formation in mice

    A myostatin and activin decoy receptor enhances bone formation in mice حسب Peter Bialek, Jascha Parkington, X. Li, Donna Gavin, Clare E. Wallace, J. Zhang, Adam Root, Guochen Yan, L. Warner, Howard Seeherman, Paul J. Yaworsky

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®

    A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART® حسب Alison Betts, Nahor Haddish‐Berhane, Dhaval K. Shah, Piet H. van der Graaf, Frank Barletta, Lindsay King, Tracey Clark, Cris Kamperschroer, Adam Root, Andrea T. Hooper, Xiaoying Chen

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Illuminating protein space with a programmable generative model

    Illuminating protein space with a programmable generative model حسب John Ingraham, Max Baranov, Zak Costello, Karl W. Barber, Wujie Wang, Ahmed Ismail, Vincent Frappier, Dana M. Lord, Christopher Ng‐Thow‐Hing, Erik R. Van Vlack, Shan Tie, Vincent Xue, Sarah C. Cowles, Alan Leung, João V. Rodrigues, Claudio L. Morales-Pérez, Alex Ayoub, Robin Green, Katherine Puentes, Frank Oplinger, Nishant V. Panwar, Fritz Obermeyer, Adam Root, Andrew L. Beam, Frank J. Poelwijk, Gevorg Grigoryan

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

    Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer حسب Adam Root, Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Jocelyn Sanford, Macy Jin, Cliona O’Sullivan, Emma Cummins, Matthew Lambert, Alfredo Darmanin Sheehan, Weijun Ma, Scott Gatto, Kelvin M. Kerns, Khetemenee Lam, Aaron M. D’Antona, Lily Zhu, William E. Brady, Susan Benard, Amy King, Tao He, Lisa Racie, Maya Arai, Dianah Barrett, Wayne R. Stochaj, Edward R. LaVallie, James R. Apgar, Kristine Svenson, Lidia Mosyak, Yinhua Yang, Gurunadh R. Chichili, Liqin Liu, Hua Li, Steve Burke, Syd Johnson, Ralph Alderson, William J.J. Finlay, Laura Lin, Stéphane Olland, W.S. Somers, Ezio Bonvini, Hans‐Peter Gerber, Chad May, Paul A. Moore, Lioudmila Tchistiakova, Laird Bloom

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: